U.S. Markets closed

Cempra, Inc. (CEMP)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
4.50-0.05 (-1.10%)
At close: 4:00PM EDT

4.45 -0.05 (-1.00%)
After hours: 5:26PM EDT

People also watch
TTPHESPRFOLDCLVSPTCT
Full screen
Previous Close4.55
Open4.60
Bid3.90 x 600
Ask13.00 x 100
Day's Range4.50 - 4.75
52 Week Range2.55 - 26.95
Volume773,540
Avg. Volume872,587
Market Cap236.27M
Beta0.96
PE Ratio (TTM)-2.08
EPS (TTM)-2.17
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.81
Trade prices are not sourced from all markets
  • Capital Cube7 days ago

    ETFs with exposure to Cempra, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube24 days ago

    ETFs with exposure to Cempra, Inc. : June 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire25 days ago

    Eight Presentations at ASM Microbe Include Late Breaker From Cempra’s Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media

    CHAPEL HILL, N.C., June 02, 2017-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...